YU81101A - Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija - Google Patents

Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija

Info

Publication number
YU81101A
YU81101A YU81101A YUP81101A YU81101A YU 81101 A YU81101 A YU 81101A YU 81101 A YU81101 A YU 81101A YU P81101 A YUP81101 A YU P81101A YU 81101 A YU81101 A YU 81101A
Authority
YU
Yugoslavia
Prior art keywords
octan
polymorphs
pharmaceutical compositions
citrate
pharmaceutical composition
Prior art date
Application number
YU81101A
Other languages
English (en)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU81101A publication Critical patent/YU81101A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Jedan kristalni polimorfni oblik citrata (monohidrat citrata) (2S,3S)-N-(metoksi-5-t-butil-fenil)metil-1-azobiciklo[2,2,2]oktan-3-amina i njegova farmaceutska kompozicija. Farmaceutska kompozicija polimorfnog oblika ukoliko monohidrat citrata ima dodatne prednosti u pogledu stabilnosti za formulaciju u lečenju povraćanja. Davanje ove farmaceutske kompozicije u obliku oralnih doza, prvenstveno u obliku tableta ili kapsula ili intravenski, dovodi do brze relaksacije.
YU81101A 1999-06-01 2000-05-18 Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija YU81101A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
YU81101A true YU81101A (sh) 2004-07-15

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
YU81101A YU81101A (sh) 1999-06-01 2000-05-18 Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija

Country Status (49)

Country Link
US (1) US6255320B1 (sh)
EP (1) EP1181290B1 (sh)
JP (1) JP3830816B2 (sh)
KR (1) KR100476606B1 (sh)
CN (1) CN1146565C (sh)
AP (1) AP2001002349A0 (sh)
AR (1) AR033331A1 (sh)
AT (1) ATE244239T1 (sh)
AU (1) AU767334B2 (sh)
BG (1) BG65240B1 (sh)
BR (1) BR0011094A (sh)
CA (1) CA2372238C (sh)
CO (1) CO5170463A1 (sh)
CY (1) CY2007011I1 (sh)
CZ (1) CZ295819B6 (sh)
DE (1) DE60003679T2 (sh)
DK (1) DK1181290T3 (sh)
DZ (1) DZ3050A1 (sh)
EA (1) EA003731B1 (sh)
EC (1) ECSP003508A (sh)
EE (1) EE200100656A (sh)
ES (1) ES2199825T3 (sh)
GT (1) GT200000087A (sh)
HK (1) HK1046284A1 (sh)
HN (1) HN2000000077A (sh)
HR (1) HRP20010904A2 (sh)
HU (1) HUP0201301A3 (sh)
IL (1) IL146406A0 (sh)
MA (1) MA26742A1 (sh)
MX (1) MXPA01012325A (sh)
MY (1) MY133508A (sh)
NO (1) NO20015848L (sh)
NZ (1) NZ515349A (sh)
OA (1) OA11956A (sh)
PA (1) PA8496101A1 (sh)
PE (1) PE20010209A1 (sh)
PL (1) PL196046B1 (sh)
PT (1) PT1181290E (sh)
SI (1) SI1181290T1 (sh)
SK (1) SK285820B6 (sh)
SV (1) SV2001000093A (sh)
TN (1) TNSN00120A1 (sh)
TR (1) TR200103473T2 (sh)
TW (1) TWI285204B (sh)
UA (1) UA66925C2 (sh)
UY (1) UY26176A1 (sh)
WO (1) WO2000073304A1 (sh)
YU (1) YU81101A (sh)
ZA (1) ZA200109775B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100834232B1 (ko) * 2004-01-30 2008-05-30 화이자 프로덕츠 인크. 액체 투여형용 베타-시클로덱스트린을 사용하는 다수회투여 제형을 얻기 위한 항균 방부제
AU2005216706B2 (en) * 2004-01-30 2007-11-29 Pfizer Products Inc. NK-1 receptor antagonists anesthesia recovery
US20070129328A1 (en) * 2004-01-30 2007-06-07 BOETTNER Wayne Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
AU2005210259A1 (en) * 2004-02-02 2005-08-18 Pfizer Products Inc. Process for preparation of 1-(2S,3S)-2-benzhydr yl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
US20140275517A1 (en) * 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL171379B1 (en) * 1991-05-31 1997-04-30 Pfizer Method of obtaining novel derivatives of quinuclidine
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
AR033331A1 (es) 2003-12-17
WO2000073304A1 (en) 2000-12-07
KR20020010688A (ko) 2002-02-04
CY2007011I2 (el) 2010-07-28
JP2003501354A (ja) 2003-01-14
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
UY26176A1 (es) 2000-12-29
DE60003679D1 (de) 2003-08-07
CA2372238C (en) 2006-12-19
MXPA01012325A (es) 2002-07-22
ATE244239T1 (de) 2003-07-15
BG106204A (en) 2002-07-31
EE200100656A (et) 2003-02-17
KR100476606B1 (ko) 2005-03-18
BG65240B1 (bg) 2007-09-28
AU4424800A (en) 2000-12-18
BR0011094A (pt) 2002-03-19
OA11956A (en) 2006-04-13
CN1353711A (zh) 2002-06-12
SK17332001A3 (sk) 2002-07-02
EP1181290B1 (en) 2003-07-02
MY133508A (en) 2007-11-30
HUP0201301A3 (en) 2002-10-28
NZ515349A (en) 2004-03-26
DZ3050A1 (fr) 2004-03-27
ECSP003508A (es) 2002-02-25
PL196046B1 (pl) 2007-11-30
AP2001002349A0 (en) 2001-12-31
SV2001000093A (es) 2001-11-08
ES2199825T3 (es) 2004-03-01
IL146406A0 (en) 2002-07-25
EP1181290A1 (en) 2002-02-27
TNSN00120A1 (fr) 2005-11-10
UA66925C2 (uk) 2004-06-15
NO20015848D0 (no) 2001-11-30
MA26742A1 (fr) 2004-12-20
PE20010209A1 (es) 2001-03-01
CO5170463A1 (es) 2002-06-27
CY2007011I1 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
DK1181290T3 (da) 2003-09-29
EA003731B1 (ru) 2003-08-28
CZ20014269A3 (cs) 2002-04-17
CA2372238A1 (en) 2000-12-07
CZ295819B6 (cs) 2005-11-16
HN2000000077A (es) 2001-02-02
PA8496101A1 (es) 2002-07-30
TWI285204B (en) 2007-08-11
EA200101108A1 (ru) 2002-04-25
AU767334B2 (en) 2003-11-06
GT200000087A (es) 2001-11-22
HUP0201301A2 (en) 2002-08-28
HK1046284A1 (en) 2003-01-03
SI1181290T1 (en) 2003-12-31
JP3830816B2 (ja) 2006-10-11
SK285820B6 (sk) 2007-09-06
DE60003679T2 (de) 2004-05-27
ZA200109775B (en) 2002-11-28
TR200103473T2 (tr) 2002-04-22
CN1146565C (zh) 2004-04-21
PL352716A1 (en) 2003-09-08
PT1181290E (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
DK1126828T3 (da) Oral indgivelse af adenosin-analoger
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
AP2003002763A0 (en) Controlled release formulations for oral administration
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
YU81101A (sh) Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija
TW200517127A (en) Novel composition
AR024411A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo[2.2.2]oct-3-ilamina y sus composiciones farmaceuticas.
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
WO2002055062A3 (en) Pharmaceutical tablet comprising paroxetine mesylate
IT1293835B1 (it) Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
DE69800210D1 (de) Wasserfreies Mittel auf Lactulosebasis
MY145885A (en) Controlled release formulations for oral administration
TH57759A3 (th) ยาเม็ดที่มีการปลดปล่อยในทันที
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
KR950016757A (ko) 약물중독 치료제 조성물
IE34397L (en) Therapeutic composition containing benzodiazepine derivative